We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · November 21, 2020

Change in Anti-VEGF and Panretinal Photocoagulation Use for Proliferative Diabetic Retinopathy

Ophthalmology Retina

 

Additional Info

Ophthalmology Retina
Anti-Vascular Endothelial Growth Factor and Panretinal Photocoagulation Use After Protocol S for Proliferative Diabetic Retinopathy
Ophthalmol Retina 2020 Jul 18;[EPub Ahead of Print], AD Azad, EM Chen, J Hinkle, N Rayess, D Wu, D Eliott, P Mruthyunjaya, R Parikh

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading